Situational Awareness
Understands your molecule or device's lifecycle stage, the decisions currently in flight, and the intelligence gaps that could cost you time or money. Establishes baseline before anything else begins.
Signal intelligence across your entire ecosystem. The fastest way to understand your market, your competitors, and how the World Model works. First step to provisioning your full World Model.
Before any module activates, Ground Truth establishes the operating reality. Three modes, all running continuously.
Understands your molecule or device's lifecycle stage, the decisions currently in flight, and the intelligence gaps that could cost you time or money. Establishes baseline before anything else begins.
Reads signals others miss — publication patterns that reveal competitor timelines, website changes that indicate strategic pivots, ClinicalTrials.gov status changes that compress your window.
Distinguishes what competitors say from what they do. Declared strategy is what appears in press releases. Revealed strategy is what appears in hiring patterns, trial designs, and regulatory filings.
Individual signals are noise. Correlated signals are intelligence. Confirmed patterns demand response.
Individually ambiguous
A competitor updates a ClinicalTrials.gov entry. A KOL starts publishing in a competing mechanism class. A field team's call frequency on a specific message drops without instruction. Individually, each is ambiguous.
Convergent signals requiring analysis
Enrollment drops at a specific trial site AND the principal investigator appeared on a competitor's advisory board AND the site's IRB just approved a competing protocol. That's not a coincidence. That's a convergent pattern requiring analysis.
Evidence-linked decisions
When additional signals converge, the system escalates from ambiguous anomaly to confirmed pattern requiring response. Connected to the specific governance ceremony where the decision is being made.
Every anomaly has two explanations. Enrollment dropped — is it because a competing trial opened, or because the study coordinator is on leave? Ground Truth presents both hypotheses.
What a competitor says in an earnings call is declared strategy. What their hiring, filing, publishing, and website behavior reveals is actual strategy. Ground Truth tracks the second one.
What was decided in headquarters and what is actually happening on the ground almost always diverge. Ground Truth bridges this gap by treating execution signals as first-class intelligence.
~80% of raw intelligence survives all four gates. The 20% that does not was never intelligence — it was noise dressed as insight.
Ingestion from 12,000+ data endpoints. Clinical registries, regulatory filings, publications, formulary feeds, digital signals. Relevance-filtered before anything enters the pipeline.
Entity resolution and fact matching. Every extracted claim linked to its source, timestamped, and validated against the molecule's Knowledge Graph.
Cross-source agreement testing. Contradictions are escalated — not silently resolved. When two sources disagree, the conflict surfaces rather than being arbitrarily resolved.
Regulatory and fair balance review. Content that fails grounding is blocked, not flagged. The system would rather say nothing than say something it cannot verify.
Ground Truth ingests from four source categories, each continuously updated. The pipeline gates determine what survives — and only verified intelligence reaches a decision.
When expertise has a common foundation, the conversation changes from debating whether a market is ready to asking what it takes to improve the specific dimension that's holding you back.
Pipeline density, differentiation, competitive vulnerability
Clinical data quality, endpoint relevance, trial design rigor
Precedent alignment, filing readiness, agency interaction history
Payer landscape, formulary positioning, access barrier severity
Cross-functional consensus, resource allocation, governance clarity
Autonomous Exploration
Most intelligence platforms answer the question you asked. Autonomous Exploration goes further — generating hundreds of variations, testing each against evidence, and surfacing the insight your team didn't know to ask for.
Every engagement starts with a customer's question. The platform doesn't just answer it — it decomposes, explores, and converges.
Rigorously, with evidence. The platform starts by delivering the direct answer — grounded in source data, cross-validated through the Evidence Engine, and contextualized against the Knowledge Graph. This alone is valuable. But it’s just the beginning.
The Agent Mesh generates 400–500 variations of the original question — exploring every angle, testing adjacent hypotheses, and probing the problem space from perspectives the team hasn’t considered. The Synthetics Layer enables massive scenario variation at scale.
The 20% of generated questions that would never surface in human brainstorming — these are the questions that change outcomes. The Rules Engine keeps exploration grounded. The Evidence Engine verifies every conclusion against source.
Start with Ground Truth for one molecule — situational awareness in four weeks. Five outputs that establish the Knowledge Graph every subsequent module builds on.
Every in-market competitor and pipeline asset. Signal history, messaging whitespace, and competitive vulnerability scoring — where are they strong, where are they exposed.
Your molecule or device's regulatory precedent, pathway comparators, and filing timeline benchmarks. What the agency has seen before. What they're likely to ask.
Formulary positioning benchmarks, payer committee timing, and access barriers mapped to your indication. The reimbursement landscape before you spend $400K researching it.
The questions your current data cannot answer — and the decisions those unanswered questions will affect. Identified and prioritized before they become expensive surprises.
The 8–12 decisions your team will face in the next 18 months, mapped to lifecycle stage, and linked to the intelligence Ground Truth has already established.
Reach out to commission your custom, evidence-grounded assessment